Index NDX, S&P 500
P/E 40.07
EPS (ttm) 13.59
Insider Own 0.42%
Shs Outstand 106.90M
Perf Week 0.51%
Market Cap 58.31B
Forward P/E 27.51
EPS next Y 19.80
Insider Trans -0.22%
Shs Float 106.60M
Perf Month 0.79%
Income 1.46B
PEG 5.14
EPS next Q 4.46
Inst Own 93.38%
Short Float 1.08%
Perf Quarter -0.59%
Sales 6.39B
P/S 9.13
EPS this Y 8.94%
Inst Trans -3.03%
Short Ratio 2.11
Perf Half Y 3.06%
Book/sh 166.49
P/B 3.27
EPS next Y 8.75%
ROA 5.13%
Short Interest 1.15M
Perf Year 23.26%
Cash/sh 1.85
P/C 293.88
EPS next 5Y 7.80%
ROE 8.59%
52W Range 441.06 - 565.00
Perf YTD -0.09%
Dividend Est. 2.73 (0.50%)
P/FCF 28.65
EPS past 5Y 7.03%
ROI 5.85%
52W High -3.60%
Beta 1.02
Dividend TTM 2.87 (0.53%)
Quick Ratio 0.45
Sales past 5Y 3.91%
Gross Margin 69.96%
52W Low 23.49%
ATR (14) 7.61
Dividend Ex-Date Apr 04, 2024
Current Ratio 0.49
EPS Y/Y TTM 24.38%
Oper. Margin 28.57%
RSI (14) 60.37
Volatility 1.33% 1.47%
Employees 16800
Debt/Eq 0.43
Sales Y/Y TTM 14.87%
Profit Margin 22.90%
Recom 1.94
Target Price 609.53
Option/Short Yes / Yes
LT Debt/Eq 0.41
EPS Q/Q 33.81%
Payout 22.02%
Rel Volume 0.68
Prev Close 544.62
Sales Surprise 1.38%
EPS Surprise 1.62%
Sales Q/Q 14.36%
Earnings Apr 26 BMO
Avg Volume 544.34K
Price 544.66
SMA20 3.42%
SMA50 1.46%
SMA200 4.00%
Trades
Volume 369,948
Change 0.01%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-22-24 Reiterated
Oppenheimer
Outperform
$580 → $650
Jan-04-24 Downgrade
TD Cowen
Outperform → Market Perform
$535
Jul-24-23 Resumed
Wolfe Research
Outperform
$558
Jun-27-23 Initiated
Jefferies
Buy
$530
May-02-23 Upgrade
Bernstein
Underperform → Mkt Perform
$490 → $525
Mar-23-23 Initiated
Mizuho
Neutral
$475
Mar-22-23 Upgrade
JP Morgan
Underweight → Neutral
$385 → $420
Mar-20-23 Initiated
Truist
Buy
$510
Feb-23-23 Upgrade
Wolfe Research
Peer Perform → Outperform
$480
Aug-17-22 Initiated
Bernstein
Mkt Perform
$505 → $490
Jan-11-22 Initiated
Bernstein
Mkt Perform
$505
Dec-17-21 Initiated
Mizuho
Buy
$550
Dec-15-21 Initiated
Wolfe Research
Peer Perform
$487
Oct-04-21 Upgrade
Raymond James
Outperform → Strong Buy
$550
Jun-30-21 Reiterated
Oppenheimer
Outperform
$505 → $560
Mar-18-21 Upgrade
Barclays
Equal Weight → Overweight
$410 → $440
Mar-17-21 Upgrade
Oppenheimer
Perform → Outperform
$460
Sep-08-20 Downgrade
JP Morgan
Neutral → Underweight
$300
Aug-25-20 Initiated
Wolfe Research
Underperform
$374
Jun-12-20 Downgrade
Oppenheimer
Outperform → Perform
Show Previous Ratings
May-22-24 08:30AM
May-21-24 12:45PM
10:00AM
May-20-24 07:04PM
May-16-24 06:45AM
09:26AM
Loading…
May-09-24 09:26AM
09:00AM
May-04-24 07:38AM
May-03-24 06:00AM
May-02-24 12:00PM
May-01-24 12:51PM
09:55AM
Apr-30-24 09:35AM
Apr-29-24 07:15PM
10:39AM
09:07AM
Loading…
09:07AM
07:40AM
06:39AM
Apr-28-24 08:20PM
Apr-27-24 03:01AM
12:01AM
(Thomson Reuters StreetEvents)
Apr-26-24 12:33PM
12:26PM
11:58AM
11:54AM
11:16AM
09:30AM
08:31AM
08:05AM
08:03AM
07:32AM
Loading…
07:32AM
07:06AM
(Associated Press Finance)
06:55AM
Apr-25-24 10:11AM
Apr-24-24 10:50AM
Apr-23-24 09:15AM
Apr-18-24 10:41AM
Apr-16-24 09:20AM
Apr-10-24 09:01AM
Apr-08-24 08:30AM
Apr-02-24 08:30AM
Apr-01-24 11:51AM
Mar-31-24 08:35AM
Mar-28-24 11:24AM
Mar-24-24 07:00AM
(The Wall Street Journal)
Mar-18-24 10:00AM
Mar-14-24 01:00PM
Mar-08-24 10:15AM
Mar-06-24 02:43PM
Mar-05-24 10:00AM
Mar-01-24 11:30AM
Feb-27-24 08:30AM
Feb-23-24 12:14PM
12:06AM
Feb-05-24 03:05PM
Feb-01-24 11:51AM
Jan-31-24 11:15PM
10:50PM
(Thomson Reuters StreetEvents)
12:17PM
(Associated Press Finance)
11:21AM
09:30AM
08:21AM
08:05AM
07:43AM
07:35AM
07:17AM
(Associated Press Finance)
06:55AM
Jan-30-24 09:03AM
Jan-26-24 09:15AM
05:36AM
Jan-25-24 08:49AM
08:44AM
08:36AM
08:35AM
08:30AM
Jan-24-24 10:00AM
Jan-23-24 09:00AM
Jan-18-24 12:00PM
Jan-17-24 10:00AM
Jan-16-24 11:20AM
Jan-12-24 01:48PM
Jan-08-24 04:20PM
Jan-04-24 08:30AM
Dec-21-23 10:32AM
Dec-15-23 02:00PM
Dec-14-23 09:09AM
Dec-13-23 09:22AM
Dec-12-23 09:53AM
Dec-08-23 08:00PM
Dec-06-23 05:10AM
Dec-05-23 05:06AM
Nov-30-23 10:51AM
Nov-24-23 11:31AM
Nov-22-23 01:43PM
Nov-16-23 11:35AM
Nov-15-23 11:40PM
07:30AM
Nov-14-23 09:33PM
12:45PM
Nov-10-23 11:35AM
Roper Technologies, Inc. is a diversified technology company, which engages in the provision of engineered products and solutions for global niche markets. It operates through the following segments: Application Software, Network Software, and Technology Enabled Products. The Application Software segment includes Aderant, CBORD/Horizon, CliniSys, Data Innovations, Deltek, Frontline Education, IntelliTrans, PowerPlan, Strata, and Vertafore. The Network Software segment is composed of ConstructConnect, DAT, Foundry, iPipeline, iTradeNetwork, Loadlink, MHA, SHP, and SoftWriters. The Technology Enabled Products segment refers to CIVCO Medical Solutions, FMI, Inovonics, IPA, Neptune, Northern Digital, rf IDEAS, and Verathon. The company was founded by George D. Roper in 1890 and is headquartered in Sarasota, FL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
WRIGHT CHRISTOPHER Director Mar 18 '24 Sale 549.71 200 109,941 35,547 Mar 19 04:02 PM WRIGHT CHRISTOPHER Director Feb 16 '24 Sale 547.00 300 164,100 35,747 Feb 20 04:05 PM JOHNSON ROBERT D Director Dec 01 '23 Sale 538.25 250 134,562 5,346 Dec 04 04:10 PM WRIGHT CHRISTOPHER Director Nov 27 '23 Sale 525.93 250 131,482 36,227 Nov 29 04:22 PM HUNN LAURENCE NEIL President and CEO Nov 09 '23 Option Exercise 125.68 7,886 991,112 128,181 Nov 13 04:16 PM HUNN LAURENCE NEIL President and CEO Nov 09 '23 Sale 511.58 13,468 6,889,907 114,713 Nov 13 04:16 PM HUNN LAURENCE NEIL President and CEO Nov 08 '23 Option Exercise 125.68 22,114 2,779,288 166,827 Nov 13 04:16 PM HUNN LAURENCE NEIL President and CEO Nov 08 '23 Sale 511.26 46,532 23,789,888 120,295 Nov 13 04:16 PM ARCHAMBEAU SHELLYE L Director Nov 01 '23 Sale 490.13 479 234,772 8,317 Nov 02 04:06 PM WRIGHT CHRISTOPHER Director Sep 15 '23 Sale 498.56 1,100 548,420 36,727 Sep 18 04:09 PM JOHNSON ROBERT D Director Sep 01 '23 Sale 500.37 250 125,092 5,596 Sep 06 04:09 PM Conley Jason EVP, Chief Financial Officer Aug 30 '23 Option Exercise 134.23 2,857 383,495 41,215 Sep 01 04:30 PM Conley Jason EVP, Chief Financial Officer Aug 30 '23 Sale 502.05 2,857 1,434,350 38,358 Sep 01 04:30 PM Conley Jason EVP, Chief Financial Officer Jul 27 '23 Option Exercise 134.23 2,143 287,655 40,501 Jul 31 04:09 PM Conley Jason EVP, Chief Financial Officer Jul 27 '23 Sale 498.00 2,143 1,067,214 38,358 Jul 31 04:09 PM JOHNSON ROBERT D Director Jul 24 '23 Sale 495.19 900 445,675 5,846 Jul 26 04:05 PM WRIGHT CHRISTOPHER Director Jun 20 '23 Sale 457.19 300 137,156 37,827 Jun 21 04:02 PM JOHNSON ROBERT D Director Jun 01 '23 Sale 450.15 250 112,538 5,903 Jun 02 01:05 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite